James B. Fink
Currently Chief Science Officer for Aerogen Pharma Corporation, San Mateo, CA.
Dr. Fink serves as Adjunct Professor for the Respiratory Therapy Program at Texas State University in Round Rock, Texas, Rush Medical School in Chicago, IL, and Visiting Professor, Department of Physical therapy, Universidade Federal de Pernambuco, Recife, Brazil. Jim has a PhD in Pharmaceutical Innovation from Bradford University, UK. Previously Dr. Fink was Technical Director of Respiratory Care Service at the Medical Center at University of California San Francisco for 14 years, Research Associate at Loyola Stritch School of Medicine, Fellow of Respiratory Science at Nektar Therapeutics and Aerogen Ltd. developing novel aerosol delivery systems for critically ill adults and infants with more than 40 issued patents, and 200+ peer reviewed papers. He is a member of the International Society of Aerosols in Medicine. Jim is a Fellow of the American Association for Respiratory Care and the American College of Chest Physicians and was awarded the 2017 Forest M. Bird Lifetime Scientific Achievement award from the American Respiratory Care Foundation